The Effect of Education on Oral Antiviral Use on Medication Compliance and Quality of Life in Patients With Hepatitis-B Diagnosis
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 60
- 主要终点
- Medication Adherence Report Scale-5
研究概览
简要总结
The aim of this study is to determine the effect of the education given to patients with CHB who use oral antiviral drugs on oral antiviral drug use on drug compliance and quality of life.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Being diagnosed with CHB for at least 6 months,
- •To be over 18 years old,
- •Using oral antiviral treatment for at least three months,
- •To be a literate person,
- •No malignancy other than hepatocellular carcinoma,
- •Not having vision and hearing problems,
- •Not having cognitive or psychiatric problems,
- •Patients/patient relatives who can use smartphones (In order to invite the patients to the 3rd and 6th month controls and to inform and remind the experimental group about the training time, they / their relatives should have and can use a mobile phone)
- •Volunteer to participate in the study.
排除标准
- ••Continuing to use alcohol after the first evaluation,
- •Not willing to participate in the study,
- •Patients with a psychiatric diagnosis,
- •Patients who do not meet the sample inclusion criteria.
结局指标
主要结局
Medication Adherence Report Scale-5
时间窗: 24 weeks
Medication Adherence Report Scale-5: Scores from the 5-point Likert-type scale vary between 5 and 25. An increase in the obtained scores indicates compatibility, and a decrease in scores indicates inconsistency.
Composite 12 İtem Short Form Health Survey
时间窗: 24 weeks
Composite 12 İtem Short Form Health Survey: It has a physical and mental component. Both the Physical Component Scale-12 and the Mental Component Scale-12 scores range from 0 to 100, with a higher score indicating better health.
MedTake Test
时间窗: 24 weeks
MedTake Test: It is used to evaluate the use of prescribed oral drugs and to numerically show patients' compliance with drug treatments. With the scale, the daily dose, time and frequency of taking the drug, its effect and reason for taking it, and its relationship with food (hungry-full) are evaluated for each drug. For these 4 parameters, patients score out of 25. In total, the level of knowledge for each drug is scored out of 100. Compliance score for all treatments is calculated with all scores of the patients. Compliance score of the participants in the study is calculated with the total compliance score obtained by each participant.
Liver Disease Symptom Index 2.0
时间窗: 24 weeks
Liver Disease Symptom Index 2.0: The scale is divided into two parts and includes 24 questions in total. The first part consists of a total of 18 questions, 9 main and 9 sub-questions, questioning the effects of the disease in the last 1 week, and the second part consists of 6 main questions questioning the effects of the disease from the time the patient learned about the disease to the present. The answer to each question in the scale receives a score between a minimum of '1' and a maximum of '5'. '1' is the lowest score; '5' represents the highest score. Higher scores from the scale indicate worse quality of life.
次要结局
未报告次要终点
研究者
Sengul KORKMAZ BINAY
Principal Investigator
Istanbul University - Cerrahpasa (IUC)